MétaCan
Menu
← Back to cohort
Record W7116894458 · doi:10.1002/alz70860_103577

The Opinions, Attitudes, and Practices of Physicians Regarding Pharmacologic Therapies for Dementia in Canada

2025· article· en· W7116894458 on OpenAlexaffabout
Ferron F. Ocampo, Joey Champigny, Krista L. Lanctôt, Mario Masellis

Bibliographic record

VenueAlzheimer s & Dementia · 2025
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsHealth Sciences CentreSunnybrook Health Science CentreCentre for Family MedicineUniversity of Toronto
Fundersnot available
KeywordsDementiaMemantineDelphi methodDiseaseRivastigmineMEDLINEAlternative medicine

Abstract

fetched live from OpenAlex

BACKGROUND: Despite the approval of disease-modifying therapies (DMTs) in select countries worldwide, cholinesterase inhibitors (ChEIs) and the NMDA receptor antagonist memantine remain the only approved pharmacologic agents for symptomatic treatment of dementia in Canada. The absence of standardized prescribing guidelines for these medications has led to significant variability in their use among physicians who care for persons living with dementia (PLWD). Furthermore, perspectives among specialists also differ regarding the significance of DMT outcomes relative to their potential risks. Our study aims to explore the opinions, attitudes, and prescribing practices of Canadian physicians concerning ChEIs, memantine, and integration of emerging DMTs in Canada. METHOD: In this cross-sectional study, we developed a semi-structured questionnaire based on published recommendation-based consensus as well as a quality-weighted literature review on pharmacologic therapies for dementia. The questionnaire is comprised of the following sections: demographic information, screening tools and diagnostics for dementia, general prescribing practices, prescribing ChEIs and memantine, monitoring of response, deprescribing, and disease-modifying therapies. The questionnaire will be sent electronically to physicians involved in the care of PLWD, including general and cognitive neurologists, geriatric psychiatrists, geriatricians, internists, and family physicians with/without care of the elderly (CoE) training across Canada. Continuous, and categorical variables will be analyzed using means and proportions. Inferential statistics will be used to explore the differences in responses across the different medical specialties. RESULT: We will send the questionnaires to at least 20 physicians per specialty across the different provinces of Canada and we will aim for a response rate of 30% (target number of participants=50), with at least 1 representative from each specialty. The demographic information of respondents will be presented as shown in Table 1. The responses for each section of the questionnaire will be presented as shown in Table 2. We will present the final results during the AAIC 2025 in Toronto, Canada. CONCLUSION: The results of this study will be utilized to create the initial (round one) questionnaire for a Delphi study to establish consensus guidelines regarding the use of ChEIs and memantine for the treatment of PLWD in Canada, as well as to inform disease-modifying medication rollout in Canada once appropriate.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.011
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.028
Threshold uncertainty score0.205

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.011
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.003
Science and technology studies0.0040.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.036
GPT teacher head0.376
Teacher spread0.340 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicDementia and Cognitive Impairment Research→French-language works237,207→